Somerset, NJ February 20, 2012 — Paul Ingram, Ph.D., European Sales Director, Clinical Supply Services at Catalent Pharma Solutions, will present “Effective global supply chain solutions for today’s clinical trial challenges” at the 3rd Annual Clinical Trial Supply China 2012, at the Renaissance Beijing Capital Hotel on Tuesday, February 28, 2012.
Dr. Ingram’s presentation will consider ways to drive clinical supply efficiency through innovative packaging, manage cold chain and import/export requirement for global trials and look at why eClinical solutions are key to global supply chain management.
Catalent’s Development & Clinical Services business offers clinical supply services, analytical chemistry, respiratory product development, regulatory consulting, and biologics cell line development. Catalent has made substantial recent investments to extend the capabilities and capacity of the business. Catalent today provides the broadest range of expert development services, which can drive more efficient development timelines, and help customers bring more compounds and better products to market faster.
Dr. Ingram has more than 15 years leadership experience in the clinical supplies industry. He is a Chartered Biologist and a Member of the Institute for Bio-Science with a Ph.D. from Strathclyde University in the UK.
The 3rd Annual Clinical Trial Supply China 2012 is co-located alongside China Bio/Pharma and Clinical Supply Chain Convention 2012 and the 2nd Annual Bio/Pharma Cold Chain China starting on Tuesday, February 28th and continuing the next day. Dr Ingram’s presentation will take place at 11.40 am in Capital Ballroom 3 (Level 3) of the Renaissance Beijing Capital Hotel. For more information on this event, please visit www.clinicaltrialssupply.com. To schedule an interview with Dr. Ingram during or after the conference, please contact Patricia McGee or Chris Halling at media@catalent.com.
To receive a copy of this presentation after the event, please visit us at www.catalent.com.
About Catalent
From drug and biologic development services to delivery technologies to supply solutions, Catalent Pharma Solutions has the deepest expertise, the broadest offerings and the most unique technologies in the industry. With over 75 years of experience, Catalent helps customers get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing and packaging solutions. Catalent employs approximately 9,400 people at 29 facilities worldwide and in fiscal year 2011 generated more than $1.6 billion in annual revenue. Catalent is headquartered in Somerset, NJ. For more information, visit www.catalent.com.
more products. better treatments. reliably supplied.™
Media Contacts:
Christopher Halling
T +44 (0) 7580 041073
chris.halling@catalent.com
Patricia McGee
T +1 (732) 537 6407
patricia.mcgee@media.com
